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ABSTRACT 
A preliminary study on the chemical constituents of Aglaia exima was 
performed.  The leaves of Aglaia exima was extracted in three different solvents: hexane, 
dichloromethane and methanol.  
The fractionation of the hexane extract of the leaves of Aglaia exima collected in 
Terengganu led to the isolation of one new cycloartane triterpenoid; cycloart-24-ene-26-
ol-3-one 203 and seven known compounds, which are four cycloartane triterpenoids;  
24(E)-cycloart-24-ene-3β,26-diol 199, vaticinone 200, schizandronic acid 201, 24(E)-
3β-hydroxycycloart-24-ene-26-al 204, one dammarane triterpenoid;  
cabraleahydroxylactone 202  and two steroids; β-sitosterol 205 (sterol) and stigmast-5-
ene-28-one 207 (sterol). The structures of compounds were analyzed and elucidated by 
using spectroscopic methods; 1D and 2D NMR, mass spectrometry, infrared 
spectrometry and X-ray.  
The hexane, dichloromethane and methanol extracts from leaves of Aglaia 
exima were subjected to biological activity screening. All isolated compounds were 
measured in vitro for their cytotoxic activities against eight cancer cell; lung (A549), 
prostate (DU-145), skin (SK-MEL-5), pancreatic (BxPC-3), liver (Hep G2), colon (HT-
29), breast (MCF-7) and (MDA-MB-231). The new cycloartane triterpenoid, cycloart-
24-ene-26-ol-3-one 203, showed potent cytotoxic activity against colon (HT-29) cancer 
cell line (IC50 11.5 μM). 
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ABSTRAK  
Kajian awal atas juzuk-juzuk kimia Aglaia exima telah dilaksanakan. Daun 
Aglaia exima diekstrak dalam tiga pelarut yang berbeza: heksana, diklorometana, 
metanol.   
Pemisahan pada ekstrak heksana dari daun Aglaia exima di Terrengganu 
menghasilkan satu sikloartana triterpenoid yang baru 24(E)-sikloart-24-en-26-ol-3-on 
203, tujuh sebatian iaitu, empat sikloartana triterpenoid sikloart-24-en-3β,26-diol 199, 
vatikinon 200, asid schizandronik 201, 24(E)-3β-hidroksisikloart-24-en-26-al 204, satu 
dammarane triterpenoid; cabraleahidroksilakton  202 dan dua steroid β-sitosterol 205 
dan stigmast-5-en-28-on 206. Struktur- struktur sebatian telah dianalisis dan ditentukan 
dengan menggunakan teknik spektroskopi; spektrometer resonansi  magnet inti (NMR), 
jisim spektrometri, spektrofotometer inframerah (IR) dan sinar x. 
Eksperimen kesan aktiviti biologi terhadap ekstrak heksana, diklorometana dan 
metanol daripada daun Aglaia exima telah diuji. Semua sebatian yang dikenalpasti telah 
diukur in vitro untuk aktiviti sitotoksik terhadap lapan barisan sel kanser, paru-paru 
(A549), prostat (DU-145), kulit (SK-MEL-5), pankreas (BxPC-3), hati (Hep G2), kolon 
(HT-29), payudara (MCF-7) and (MDA-MB-231). sikloartana triterpenoid yang baru 
24(E)-sikloart-24-en-26-ol-3-on 203 menunjukkan aktiviti sitotoksik berpotensi pada 
barisan sel kanser kolon (HT-29) (IC50 11.5 μM). 
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1.1 INTRODUCTION 
The tropical rain forest of Malaysia is known to be one of the most diversified 
ecosystems on earth
1
. The diversity of flora in Malaysia is estimated to comprise of 
7900 species of flowering plants and 1500 genera of seed plants (Whitmore, 1984). The 
high amount of rainfall, which is over 2200 mm a year, favorably supports the growth 
of trees, tall shrubs, ferns and climbers
1
. The richness of plants contributes to the 
existence of enormous variety of natural products which have strong impact towards 
human culture.  Hence, it provides scientist an interesting resource for research.  
Natural products are commonly termed as ‘secondary metabolites’ which have 
pharmacological properties and biological effect to human. Many are insecticidal, 
fungicidal, phytotoxic, anti-inflammatory, anti-cancer and anti-bacterial. Some plays a 
protecting role to the plants from herbivores and microbial infection.  They can also act 
as defense compounds against herbivores and pathogens as flower pigments that attract 
pollinators, or as hormone or signal molecules. Some are used as medicine to treat 
human disorders and infections due to their pharmacological properties
2
. 
Due to the high medicinal value and biological effects to human, natural 
products play a highly significant role in drug discovery until now and was proved by 
the analysis of the number of natural products derived drugs present in the total drugs 
launched from the 1981 to 2002 demonstrated by Newman et al
3
. According to the 
study, natural products were concluded as significant source of new drugs and have 
enormous influence especially in the anti-hypertensive area. In addition, another study 
showed that more than 80% of drug molecules are natural products or natural 
compounds inspired
4
. 
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In addition, natural products derived drugs were also proven to contribute 
significantly to the profitability of many pharma and biotech companies. They are well 
represented as top 35 of worldwide selling ethical drug sales of 2000, 2001 and 2002
5
. 
Table 1.1 shows the ranking of natural product- derived drugs in top 35 worldwide 
selling ethical drug sales for 2000, 2001 and 2002. 
Table 1.1: Ranking and Function of Natural Product-Derived Drugs in Top 35  
Worldwide Ethical Drug Sales for 2000, 2001 and 2002 
NP-derived drugs
a 
Rank 
2000 2001 2002 
Atorvastatin 
- lower blood cholesterol (Hochadel, 2006) 
2 1 1 
Simvastatin 
- lower blood cholesterol (Hochadel, 2006) 
3 3 2 
Estrone 
- estrogen replacement therapy (Ravina, 2011) 
16 16 25 
Amoxicillin + Clavulanic acid 
- kills bacteria growth caused by infection (Hochadel, 2006) 
17 17 27 
Enalapril 
- controls high blood pressure by relaxing blood vessels 
(Hochadel, 2006) 
18 - - 
Pravastatin (BMS) 
- lower blood cholesterol (Hochadel, 2006) 
19 15 15 
Pravastatin (Sankyo) 
- lower blood cholesterol (Hochadel, 2006) 
23 31 - 
Paclitaxel 
- disrupting cancer cell growth, affective in late stage ovarian, 
breast and lung cancer (Dubin, 2001) 
25 - - 
Azithromycin 
- treat bacterial infections in different part of body (Hochadel, 
2006) 
27 29 33 
Ribavirin 
- block virus replication (St. Georgiv, 2010) 
28 30 11 
Gabapentin 
- treat epilepsy (Wyllie, 2006) 
30 23 14 
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NP-derived drugs
a Rank 
2000 2001 2002 
Fluticasone propionate 
- maintenance treatment of asthma (Spratto, 2009) 
31 33 - 
Clarithromycin 
- treatment of pneumonia (Yaffe, 2010) 
32 - - 
Cyclosporine 
- prevent rejection with kidney, liver and heart transplantation 
(Lahita, 2004) 
34 - - 
Lisinopril 
- controls high blood pressure by relaxing blood vessels 
(Hochadel, 2006) 
35 - - 
Salmeterol + Fluticasone propionate 
- treat asthma (Page, 2004) 
- - 13 
Oxycodone HCl 
- relieve or control moderate to severe pain (Freye, 2008) 
- - 32 
a
 NP-derived drug indicates that the drug is either a NP, a semisynthetic derivative of a NP, or a 
synthetic drug that is modeled on a NP pharmacophore. 
In view of the importance of natural products in the pharmaceutical industry, the 
author has conducted a study on Aglaia exima from the family Meliaceae collected from 
Terengganu. The chemical constituents of the plant were sent for cytotoxic activity tests 
against various cell lines such as skin, colon, pancreas, lung, prostate, breast and liver. 
1.2       OBJECTIVES OF THE STUDY: 
The objectives of this study are as follows: 
i.    To isolate the chemical constituents of Aglaia exima. 
ii.   To elucidate and identify the structure of chemical constituents isolated from Aglaia 
exima by spectroscopic methods: NMR, UV, IR, mass spectrometry and X-ray 
analysis. 
iii.  To evaluate the cytotoxicity of the isolated compounds against selected cancer cell 
lines.  
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1.3       MELIACEAE 
The Meliaceae or Mahogany family comprises 50-52 genera with about 550 
species, mostly found in the tropical region of Asia, Africa, Australia, and South 
American
6
. Some aspects of Meliaceae are discussed briefly in the following paragraphs.  
1.3.1    DISTRIBUTIONS
7,8
 
Plants of Meliaceae are very common trees or shrubs with flowers and under 
storey of lowland primary forest. The plants belonging to Meliaceae were best 
represented in the Malesian region, the Malay peninsula alone has more species (91 
species in 17genera) than the whole of Africa (84 species). Plants from this family 
usually utilized for medicine and other purpose. Some plants from genera Melia were 
effective against insects.   
1.3.2      GENERAL APPEARANCE AND MORPHOLOGY
9
 
 Meliaceae belongs to Order Rutales s. str. comprising Rutaceae, Meliaceae, 
Simaroubaceae, Cneoraceae and Burseraceae (Waterman & Grundon 1983). It can be 
classified from the different family by its specific features of leaves mostly pinnate, not 
glandular punctuate, exstipulate, spirally arranged, trifoliolate, with a single blade or 
rarely bipinnate. Leaflets usually entire rarely lobed or serrate. Flower usually unisexual, 
with well developed rudiments of opposite sex, in cymose panicles, petals are three to 
six but usually five, sometimes joined at the base, usually is one whorl, green, white, 
cream, pink to claret and violet or yellow. Calyx usually lobed, sometimes with 3-5 
sepals. Anthers in 1 or, rarely, 2 or more whorls, sometimes locellate, at tips of 
filaments or at the margin of the tube or within its throat. Stamens are usually eight to 
ten, in a filamental tube on base of the disc with or without lobes. Ovary is locular, each 
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locule with one to many ovules. Fruits are often a drupe, berry or a capsule. Seeds are 
few, large, usually arillate or winged. 
1.3.3    THE ECONOMIC AND BIOLOGICAL IMPORTANCE
9
 
Recently, many phytochemists and biologists are highly interested on Meliaceae, 
because many compounds with insect-antifeeding, insect-repellent or and insecticidal 
properties were found, and many members of this family are highly esteemed in 
traditional medicine of most continents. Walsura monophylla is commercially tested for 
treatment of cancer. Besides, some are edible tropical fruits. Aglaia dookkoo Griff. or 
known as Lansium domesticum Jack is the well known tropical fruit in Malaysia. Many 
other species from this family have different and useful economic usage and table below 
lists the use of some Meliaceous plants. 
Table 1.2: List of the Usage of Some Meliaceous Plants 
Species Usage 
Chisocheton and Aphanamixis sp. The oil from seeds used as an illuminant 
Azadirachta excelsa Leaves as green vegetables 
Melia azedarach Foliage and fruits used as a febrifuge and vermifuge 
Azadirachta indica Neem from leaves used as a powerful insecticides 
 
 
 
 
 
 
 
Introduction                                                                                                         Chapter 1 
6 
 
1.3.4    CLASSIFICATION OF FAMILY MELIACEAE
 
 
 
                                                                                       Sub- family 
 
 
                       Genus                                          Genus                                           Genus                   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
______________________________________________________________________ 
Scheme 1.1: Classification of family Meliaceae
8
 
 
 
 
Meliaceae 
Cedreloideae 
Cedrela 
Toona 
Meliodeae Swietenioideae 
Aglaia 
Aphanamixis 
Azdirachta 
Carapa 
Chisochetan 
Dysoxylum 
Lansium 
Turraea 
Sandoricum 
Xylocarpus 
Guareeae 
Trichilia 
Turraea 
Walzura 
 
Swietenia 
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1.4       GENUS; AGLAIA
10
  
Genus Aglaia has a total of 105 species belonging to family Meliaceae. It is the 
largest genus of Meliaceae. The trees are mainly found in subtropical and tropical forest 
of southern mainland China, Indo-Malaysian region and the Pacific Island.  
1.4.1    DISTRIBUTION AND HABITAT
9 
Some of the species are tall trees and occasionally emergent, some are 
undergrowth treelets, which may be unbranched, and others are rheophytes. At least two 
species, A. elaeagnoidea and A. brownie, are frequently and A. lawii is sometimes 
littoral; A. cucullata is found in tidal estuaries and mangrove swamps.  
1.4.2    GENERAL APPEARANCE AND MORPHOLOGY
9,11,12 
Leaves from this genus are alternate, lanceolate, oblanceolate, ovate, obovate, 
elliptical or oblong, the lamina which usually of moderate thickness, sometimes 
membraneous or coriaceous. Inflorescence usually axillary or supra-axillary. Flowers 
unisexual with well developed rudiments of the opposite sex. The small different 
between female and male is female inflorescence usually smaller and less-branched but 
flower always larger than in the male. It has only five anthers. Calyx is in a cup-shaped 
and it consists of 5 free sepals which are slightly grown together at the base. Corolla is 
with 3-5 petals, free or united at the base, free from the staminal tube or partially united 
to it, usually yellow, sometimes pink or white. Disk is absent in the plant from genus 
Aglaia. Ovary is locular, superior, depressed-globose or ovoid with dense stellate hair or 
peltate scales, locules with 1 or 2 collateral or superposed ovules, placentation axial, 
style 1, stigma ovoid. Fruits are in subglobose, obovoid or ellipsoid, indehiscent or a 
loculicidal capsule. Seeds are large, with an aril or sarcotesta covering the seed. 
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1.4.3    KNOWN ECONOMIC AND BIOLOGICAL IMPORTANCE
11 
Many of the species of Aglaia have traditionally been used for medicinal 
properties in several countries (Table 1.3). Plants of Aglaia are used for the treatment of 
inflammatory skin diseases and allergic inflammatory disorders such as asthma in 
Vietnam
13
. In several of Southeast Asia countries including China and Vietnam, Aglaia 
plants are traditionally used as insecticides which kill insects
14
. Besides, the wood of 
Aglaia sometimes can be used for construction or making furniture. The fleshly layer 
around the seeds of some species is edible, Aglaia dookkoo Griff. or known as Lansium 
domesticum is the tropical fruits, langsat. Aglaia korthalsii are widely grown for their 
fruits in villages in the north of Peninsular Malaysia, Kelantan. The flowers of A. 
odorata Lour. are known to be used as tea flavour.  
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Table 1.3: List of some Aglaia species used in traditional treatments of several countries 
Aglaia species Parts of Plant Treatments 
   A. elliptica
15
 Bark - In Philippines, it was boiled to treat 
tumors 
Leaves -     In Philippines, it was applied to 
wounds 
A. roxburghiana
16
  - Treats inflammation, leprosy, throat 
infections, billous and febrile 
complaints 
A. odorata
17
  - Used as heart stimulant, febrifuge, 
for the treatment of coughs, 
inflammations and injuries 
A. lawii
18
  - In Vietnam, it was used to treat 
bacterial infection, liver and tumor 
diseases 
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2.1       GENERAL   
The previous investigation on the isolation of chemical compounds and 
biological activity of the plants from family Meliaceae has been performed by scientists 
from worldwide due to the richness of active natural products, triterpenoids, limonoid, 
sesquiterpenes and sterols. Many of these compounds have strong biological activities 
such as anticancer, anti-inflammatory and insecticidal. A plenty of studies on Aglaia 
species were performed, an immense amount of active biological compounds have been 
found, as genus Aglaia is the largest genus in family Meliaceae
5
.  The studies of general 
characteristic and chemical constituents found in the family Meliaeceae and genus 
Aglaia will be shown in this section. 
2.2       TERPENES
19,20,21,22 
Terpenes are a class of hydrocarbons in which structures are multiples of five-
carbon isoprene units (2-methyl-1,3-butadiene) 1. Therefore, its general formula is 
(C5H8)n. Terpenoids are oxygen-containing analogs of the terpenes, it has been further 
functionalized. Both terpenes and terpenoids comprise the largest group of natural 
products in plants and animals. All terpenes are formed by the condensation of two or 
more isoprene units and characterized by the number of five-carbon isoprene unit which 
they contain. For example, triterpenes are C30 compounds that contain six isoprenes 
units. Squalene, an acyclic triterpenes which is formed by a head-to-tail condensation of 
two sesquiterpenes (farnesylpyrophosphate) units plays a significant role as precursor of 
sterols
23
. Terpenes can be classified into hemiterpenes, monoterpenes, sesquiterpenes, 
diterpenes, sesterpenes, triterpenes, tetraterpenes, polyterpenes. The table below shows 
the classifications and example of terpenes. 
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Table 2.1: Classification of Terpenes According to Isoprene Units and Their Examples 
Class 
Molecular 
formula 
Isoprene 
units 
Examples 
Hemiterpenes C5H8 1 Isoprene 1 
Monoterpenes C10H16 2 Linalool 2, Myrcene 3 
Sesquiterpenes C15 H24 3 Zingiberene 4 
Diterpenes C20 H32 4 Carnosol 5, Cembrene 6 
Sesterterpenes C25 H40 5 Geranylfarnesol 7 
Triterpenes C30 H48 6 Squalene 8 
Tetraterpenes C40 H64 8 β-carotene 9 
Polyterpenes (C5 H8)n >8 Natural rubber 10 
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2.3      TRITERPENOIDS
24,25,26 
Triterpenoids are the largest group among various terpenoid groups with 4000 
different molecules and 40 skeletal types. They are compounds with a carbon skeleton 
based on six-isoprene units which are derived from the squalene 8 biosynthetically. The 
existence of more than one type of triterpenoids was due to the different type of ring 
closure in this acyclic intermediate, squalene 8. They are further classified as acyclic, 
monocyclic, bicyclic, tricyclic, tetracyclic, pentacyclic triterpenoids according to the 
number of rings present in the molecule (see Table 2.2). Tetracyclic as steroidal types 
(C-27) and pentacyclic (C-30) were the major groups. Most of the triterpenoids are 
either tetracyclic or pentacyclic. The tetracyclic triterpenoid belongs to the important 
class of compound (Chapter 2.4), the steroids, which are considered separately. It will 
be discussed in the following section. Pentacyclic triterpenoids with six-membered ring 
are of higher plant origin. The table below shows the general structures of each types 
and classes of triterpenoids found in Meliaceae.  
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Table 2.2: Types and Classes of Triterpenoids Found in Meliaceae
27
 
Acyclic 
 
Squalene 8 
Monocyclic 
HH
 
Presqualene 11 
  
Iridogermane 12 
Bicyclic 
 
Lansane 13 
Tricyclic 
 
Malabaricane 14 
H
 
Ambrane 15 
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Tetracyclic 
R1
       
R1 = OH or O 
Protostane 16 
R1
 
R1 = OH or O 
Dammarane 17 
R1  
R1 = OH or O 
Lanostane 18 
R1
 
R1 = OH or O 
Tirucallane/ euphane 19 
R1
 
R1 = OH or O 
Apotirucallane 20 
R1
 
R1 = OH or O 
Cycloartane 21 
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Pentacyclic 
R1
R2
 
                   R1 = OH or O 
R2 = CH3 or COOH 
Lupane 22 
R1
R2
 
                       R1 = OH or O 
R2 = CH3 or COOH 
 
Moretane 23 
R1
R2
 
                   R1 = OH or O 
R2 = CH3 or COOH 
Ursane 24 
R1
R2
 
                       R1 = OH or O 
R2 = CH3 or COOH 
Oleanane 25 
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2.3.1    BIOSYNTHESIS OF TRITERPENOIDS
25,26,27,28,29,30,31,32 
Squalene 8 is the precursor of all triterpenoids and steroids. A variety of 
triterpenoids is formed depends on the stereoselectively cyclization and structurally 
rearrangement of squalene 8 or squalene 2,3-epoxide 26 in a single enzyme-catalyzed 
reaction. The product of squalene epoxide 26 depends on the conformation that 
squalene epoxide 26 assumes in binding to the cyclase and the nature and position of the 
nucleophile or base in the enzyme.  
O  
26 
Table 2.3: The Major Groups of Terpenoids as the Important Precursors of All Steroids 
in Plants Which Produced from the Cyclization.  
Tetracyclic triterpenoids Pentacyclic triterpenoids 
Dammarane 17 Lupane 22 
Tirucallane/ Euphane 19 Ursane 24 
       Cycloartane 21 Oleanane 25 
Hereunder the biosynthesis of these triterpenoids is described starting from the 
acetylcoenzyme A (acetyl-CoA) 28 (Scheme 2.1). 
The biosynthesis of squalene 8 was initiated by converting six molecules carbon 
dioxide and six molecules of oxygen under sunlight to the glucose molecule, which 
break down through glycolysis to pyruvic acid 27. The pyruvic acid 27 is converted to 
enolate acetyl coenzyme A 28 which will couple with another enolate acetyl coenzyme 
via Claisen-type condensation mediated by the enzyme acetoacetyl-CoA thiolase to 
form acetoacetyl coenzyme A 29. The acetoacetyl coenzyme A 29 react with enolate 
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acetylcoenzyme A 28 via aldol condensation to form 3-hydroxy-3-methylglutaryl 
coenzyme A (HMG-CoA) 30, which is then forms the key intermediate, (3R)-mevalonic 
acid (MVA) 31 by NADPH and catalysed by enzyme hydroxymethylglutaryl-CoA  
reductase. The (3R)-mevalonic acid (MVA) 31 is then converted into 
isopentylpyrophosphate (IPP) 34 through three successive phosphorylation progressing 
via (3R)-mevalonate-5-phosphate (MVAP) 32 and (3R)-mevalonate-5-pyrophosphate 
(MVAPP) 33, which are catalysed by the enzyme mevalonate kinase (MVAK), 
mevalonate 5-phosphate kinase (MVAPK), and mevalonate 5-pyrophosphate 
decarboxylase (MPD), respectively. It followed by the decarboxylative elimination to 
yield the IPP 34. It is then undergoes isomerisation to its allylic isomer, 
dimethylallylpyrophosphate (DMAPP) 35 catalysed by the enzyme 
isopentyldiphosphate isomerase (Scheme 2.1). 
Condensation of the DMAPP 35 and IPP 34 gives geranyl pyrophosphate (GPP) 
36, a precursor of monoterpenes which then couples with IPP 34 to give farnesyl 
pyrophosphate (FPP) 37. The biosynthesis of farnesyl pyrophosphate (FPP) 37 is 
catalysed by the enzyme farnesyl pyrophosphate synthase (FPS). The FPP 37 and GGPP 
38 are precursors of sesquiterpenes and diterpenes respectively. Two molecules of 
farnesyl pyrophosphate (FPP) 37 couple with each other to form presqualene-
pyrophosphate (PSPP) 39, which undergoes reductive arrangement to furnish squalene 8. 
Squalene-2,3-oxide 26 is formed from the epoxidation of squalene catalysed by the 
enzyme squalene epoxidase (SE). Different types of tetracyclic and pentacyclic 
triterpenoids are formed according to the free rotation of five C-C bonds when binding 
the squalene 8 or squalene-2,3-oxide 26 in conformation to the active site of the cyclase 
(Scheme 2.2). 
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The dammarane type triterpenoids are furnished through the chair-chair-chair-
boat cyclization of squalene-2,3-epoxide 26 which leads to a dammarenyl cation 40. 
This cation then undergoes a series of Wagner-Meerwein migration with the sequence 
of 1,2-hydride followed by 1,2-methyl shifts and then terminated by the loss of proton 
to form euphol 41, a triterpenoid  where dammarane skeleton found (Scheme 2.3). 
Besides this, chair-boat-chair-boat cyclization leads to the cycloartane group and 
steroids in plants (Scheme 2.3). Upon the cyclization, a transient protosteryl cation 42 is 
formed and then undergoes a series of Wagner-Meerwein firstly 1,2-hydride shifts then 
1,2-methyl shifts until a proton loss from C-10 methyl forming a cyclopropane ring and 
hence creating cycloartenol 43 (Scheme 2.4). 
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_____________________________________________________________________________ 
Scheme 2.1 Biosynthesis of isopentenyl diphosphate (IPP) and dimethylallyl diphosphate 
(DMAPP)  
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OPP
36
FPS
monoterpenes
OPP
36
OPP
OPP
H
PPO
34
35
H
34
OPP
37
sesquiterpenes
OPP
37
OPP
H
34
OPP
38
diterpenes
tetraterpenes
OPP
37
OPP
37
Enz-X
PPO
30
NADPH NADP
SE
O
8 26  
 ______________________________________________________________________  
Scheme 2.2 Biosynthesis of squalene 8 and squalene-2,3-oxide 26, the precursor of steroids and  
triterpenoids 
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_____________________________________________________________________________ 
Scheme 2.3 Cyclization of squalene oxide to dammarane-type triterpenoids 40 and euphol 41  
(chair-chair-chair-boat cyclization) 
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_____________________________________________________________________________ 
Scheme 2.4 Cyclization of squalene epoxide 26 to cycloartane- type triterpenoids (chair-boat-
chair-boat cyclization) 
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2.4       STRUCTURES AND BIOSYNTHESIS OF STEROIDS
26,33,34,35
 
Steroids are plant metabolites considered to be a tetracyclic terpenes-derived 
natural products synthesized via the mevalonic acid (MVA) 31 in the cytoplasm of 
plants and animals. Each has a complex basic ring and side chain structure which made 
up by four rings of three cyclohexane and a cyclopentane ring. With the characteristic of 
four ring structure, they are used as the starting material for the production of many 
hormones. Hereunder the four rings designated by A, B, C and D that made up of the 
skeleton of steroids. 
HO
R19
3
4
5 7
810
9
11
12
14
13
15
16
17
2
1
18
6
B
C D
A
 
All steroids have the same basic tetracyclic structure but differ in their 
substituent group, R, sometimes aliphatic or functionalized attached to ring D. The 
steroids molecules are flat, two methyl groups at position 10 and 13 on the ring located 
above the molecule plane. On the other hand, some steroids have more complicated ring 
and side chain structures.  
Steroids can be found in both animals and plants. For example, cholesterol 44 is 
the main steroid found in vertebrates but it also can be found in plants and in small 
quantity in some algae. In higher plants, mainly C28 (total of 28 carbons) and C29 (total 
of 29 carbons) sterols which mainly comprise of sitosterol 47 and stigmasterol 48 are 
found. Both sterols can be termed as phytosterol. Besides, invertebrates possess a 
mixture of C26, C27, C28 and C29 sterols. Red algae contain C27 sterols while brown and 
green algae contain C29 sterols. No steroids were appeared in prokaryotes.  
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 Table 2.4: Some typical steroids in plants. 
Name of Compounds Structures 
Cholesterol 44 
C27 
HO
19
3
4
5 7
810
9
11
12
14
13
15
16
17
2
1
18
6
20
21 22
23
24
25
26
27
 
44 
Campesterol 45 
C28 
HO
19
3
4
5 7
810
9
11
12
14
13
15
16
17
2
1
18
6
20
21 22
23
24
25
26
27
28
 
45 
        Brassicasterol 46 
C28 
HO
19
3
4
5 7
810
9
11
12
14
13
15
16
17
2
1
18
6
20
21 22
23
24
25
26
27
28
 
46 
Sitosterol 47 
C29 
HO
19
3
4
5 7
810
9
11
12
14
13
15
16
17
2
1
18
6
20
21 22
23
24
25
26
27
28
29
 
47 
General Chemical Aspects                                                                                  Chapter 2 
26 
 
Stigmasterol 48 
C29 
HO
19
3
4
5 7
810
9
11
12
14
13
15
16
17
2
1
18
6
20
21 22
23
24
25
26
27
28
29
 
48 
  
Squalene 8 is a precursor of cycloartenol 43 and cholesterol 44 which in turn is 
the precursor of other steroids. The commonest phytosterol, sitosterol 47 and 
stigmasterol 48 were found in plant Aglaia exima.  
Hereunder the plausible biosynthesis route of steroids and phytosterol. The 
opening of the cyclopropane ring of cycloartenol 43 probably occurs after loss of the 
4α-methyl group and before loss of the C-14 methyl group in the same order as found in 
the biosynthesis of cholesterol (animal). It also involves the C- methylation of the sterol 
side chain at C-24 which is an important area of biochemical difference between 
animals and fungi, as well as plants. 24(28)-methylenecycloartanol 49 formed from 
cycloartenol 43 through the first C- methylation reaction and the hydride transfer from 
C-24 to C-25 is catalyzed by sterol methyl transferase. The loss of C-14 methyl 
converted 24(28)-methylenecycloartanol 49 to obtusifoliol followed by the double bond 
rearrangement which furnish 24(28)-methylenelophenol 52. It was continued by C- 
methylation, loss of 4α- methyl group and double bond rearrangement occurred to form 
stigmasterol 48 and sitosterol 47 from citrastadienol 53 (Scheme 2.5). 
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Cycloartenol 43
HO
HO
HO
HO
HO HO
ii. Hydride transfer
24(28)-methylenecycloartanol 49
cycloeucalenol 50
Demethylation Methylation
citrostadienol 53
Demethylation
47 48
obtusifoliol 51
24(28)-methylenelophenol 52
HO
Demethylation
i. Methylation
Demethylation
Double bond
rearrangement
HO
Hydrogenation
 
 
_____________________________________________________________________________ 
Scheme 2.5 Biosynthesis of steroids and phytosterol (sitosterol 47 and stigmasterol 48) 
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2.5       CHEMICAL CONSTITUENTS OF AGLAIA SPECIES 
Many biologically active compounds were found from Aglaia species by 
extensive research of scientists. Below are the compounds that obtained from different 
part of plants of Aglaia sp.. 
Table 2.5: Chemical Constituents Found in Aglaia sp.  
Types of 
Compounds 
Aglaia sp. Compounds 
Cyclopenta[bc] 
benzopyran 
A. forbesii
36,37 
Desacetylpyramidaglains A 54 
Desacetylpyramidaglains C 55 
Desacetylapyramidaglains D 56 
 Aglaforbesins A 58 
Aglaforbesins B 59 
A. forbesii
37 
A. argentea
37
 
Aglains A 57 
A. edulis
38 
Thapsakin B 60 
Isothapsakin B 61 
Homothapsakin A 62 
Thapsakin A acetate 63 
Thapsakon A 64 
Thapsakon B 65 
A. testiculari
39 
Aglaxiflorin D 66 
A. argentea
37 
Aglains B 67 
Aglains C 68 
A. ponapensin
40
 Ponapensin 69 
A. grandis
41
 Grandiamides A 70 
A. foveolata
42
 Foveoglin A 71 
Foveoglin B 72 
Isofoveoglin 73 
Cyclofoveoglin 74 
Secofoveoglin 75 
Benzo[b] 
oxepine 
A. edulis
38,43 
Edulisones A 76 
Edulisones B 77 
Thapoxepine A 78 
Homothapoxepine A 79 
Thapoxepine B 80 
A. forbesii
37 
Forbaglin A 81 
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Types of 
Compounds 
Aglaia sp. Compounds 
Cycopenta[b] 
benzofuran 
A. edulis
38 
Aglaroxin A 82 
Pannellin 83 
A. tomentosa
44
 
A. forbesii
37
 
A.crassinervia
45
 
A. ferruginaea
46 
A. oligophylla
47
 
Rocaglaol 84 
A. forbesii
37 
Ethylrocaglaol 85 
A. argentea
37 
A. elliptica
48
 
Didesmethylrocaglamide 86 
A. odorata
49 
C-3’-hydroxyaglain C 87 
C-19,C-3’-dihydroxyaglain C 88 
C-19-hydroxy,C-3’-methoxyaglain C 89 
A. elliptica
48
 
A. 
elaeagnoidea
50 
Rocaglamide 90 
Methyl rocaglate 91 
A. duperreana
51
 C-1-O-acetyldemethylrocaglamide 92 
A. spectabilis
52 
C-1-O-acetyl-4’-demethoxy-3’,4’-
methylenedioxy derivative of methylrocaglate 
93 
A. elliptica
51,52 4’-demethoxy-3’,4’-methylene-dioxy-methyl 
rocaglate 94 
1-O-formyl-4’-demethoxy-3’,4’-
methylenedioxy-methyl rocaglate 95 
4’-demethoxy-3’,4’-methylenedioxyrocaglaol 
96 
1-oxo-4’-demethoxy-3’,4’-
methylenedioxyrocaglaol 97 
A. spectabilis
52
 4C-3’methoxy derivative of methylrocaglate 98 
A. odorata
49 
C-3’-methoxyrocaglamide 99 
C-3’-methoxylrocaglaol 100 
C-1-oxime 101 
C-3’-hydroxydidemethylrocaglamide 104 
A. duperreana
51 
C-3’-hydroxyrocaglamide 102 
C-1-O-acetyl-3’-hydroxyrocaglamide 103 
A. foveolata
42 
Silvestrol 105 
Cycloartane A. forbesii
36 
23,24,25-trihydroxycycloartan-3-one 106 
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Types of 
Compounds 
Aglaia sp. Compounds 
Cycloartane A. harmsiana
53
 
 
(24R)-cycloartane-3β,24,25-triol 107 
(24R)-cycloartane-3β,24,25,28-tetrol 108 
(24R)-cycloartane-3α,24,25-triol 109 
A. 
roxburghiana
54
 
Roxburghiadiol A 110 
Roxburghiadiol B 111 
A. argentea
55 
Argenteanones A 112 
Argenteanones B 113 
Argenteanol 114 
Pregnane 
steroids 
A. forbesii
36 2β,3β -dihydroxy-5α-pregn-17(Z)-en-16-one 
115 
A. tomentosa
44 
Aglatomin A 116 
A. lawii
56
 (E)-Aglawone 117 
A. tomentosa
44 
Aglatomine B 118 
A. silvestris
57
 Pregnacetal 119 
A. ponapensin
40 
E-volkendousin 120 
A. grandis
58
 2β,3β-dihydroxy-5α-pregnane-16-one 121 
2β,3β-dihydroxy-5α-pregn-17(20)-(Z)-en-16-
one 122 
Bisamides A. forbesii
36 
A. foveolata
42 
Pyramidatine 123 
A. edulis
59
 Aglaiduline 124 
Aglaithioduline 125 
Aglaidithioduline 126 
A. tenuicaulis
60
 Pyrrolotenin 127 
Secopyrrolotenin 128 
A. testicularis
39 
A. odorata
49 
Piriferine 129 
Odorinol 130 
A. argentea
37 
A. oligophylla
47 
Odorine 131 
A. oligophylla
47 2’-epi-odorine 132 
A. grandis
41 
Grandiamides B 133 
Grandiamides C 134 
Amide ester A. tenuicaulis
62 
Tenucaulin A 135 
Isotenucaulin A 136 
Tenucaulin B 137 
Aglatenin 138 
Tenaglin 139 
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Types of 
Compounds 
Aglaia sp. Compounds 
Amide ester A. tenuicaulis
62
 Caulitenin 140 
Amide alcohol A. tenuicaulis
62 
Aglatenol 141 
Dammaranes A. lawii
44 
Aglinins A 142 
Aglinins B 144 
A. lawii
44
 
A. foveolata
61
 
Eichlerianic acid 143 
Foveolins A 145 
A. oligophylla
47
 
A. lawii
58 
A. tomentosa
44 
Cabraleone 146 
Cabraleadiol monoacetate 149 
Cabraleadiol 150 
A. tomentosa
44 
A. foveolata
63 
3-epiocotillol 148 
A. tomentosa
44 
Cabraleadiol 3-acetate 147 
Aglinin D 151 
Aglinin C 152 
A. oligophylla
47 
Ocotillone 153 
Ocotillol 154 
A. 
elaeagnoidea
50 
20S,24S-epoxy-25-hydroxydammaran-3-one 
155 
20S,24S-epoxy-25-hydroxy-methyldammaran-
3-one 156 
A. tomentosa
44 
Cabralealactone 157 
Cabralealactone 3-acetate 158 
A. 
crassinervia
45 
3-epi-Cabraleahydroxylactone 159 
A. silvestris
59,62 
Silvaglenamin 160 
Silvaglin A 161 
Isosilvaglin A 162 
Desoxysilvaglin 163 
Methylisofoveolate B 164 
Methylfoveolate B 165 
Aglasilvinic acid 166 
Isoeichlerianic acid 167 
Methylisoeichleriate 168 
A. ignea
63
 Dammarenolic acid 169 
A. oligophylla
47 
Dipterocarpol 170 
20(S),24(S)-dihydroxydammar-25-en-3-one 
171 
20S,25-epoxy-24R-hydroxy-3-dammaranone 
172 
20S,25-epoxy-24R-hydroxydammarane-3α-ol 
173 
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Types of 
Compounds 
Aglaia sp. Compounds 
Dammaranes A. foveolata
42,63 
Foveolins B 174 
Dymalol 175 
17,24-epoxy-25-hydroxy-21-methoxy-3,4-
seco-baccharane 176 
Tirucallane A. leucophylla
64
 (-)-leucophyllone 177 
(-)-niloticin 178 
(-)-bourjortinolone 179 
(-)-piscidinol 180 
Lignan A. testicularis
39 
Secoisolariciresinol dimethyl ether 181 
A. 
elaeagnoidea
50 
Trans-3,4-bis(3,4,5-trimethoxy-benzyl)-
tetrahydrofuran 182 
Trans-3,4-bis(3,4,5-trimethoxy-benzyl)-1,4-
butanediol diacetate 183 
A. cordata
65
 Aglacins E 184 
Aglacins F 185 
Aglacins G 186 
Aglacins H 187 
Glabretal A. 
crassinervia
45 
Aglaiaglabretol A 188 
Aglaiaglabretol B 189 
Aglaiaglabretol C 190 
Aminopyrrolidin
e 
A. odorata
49 
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3.1       COMPOUNDS OF AGLAIA EXIMA 
Eight compounds were obtained from Aglaia exima (KL 4762) which was 
collected from H.S Kepayang, Pahang, Malaysia on 26 November 1997 and has been 
deposited at the Herbarium of Department of Chemistry, University of Malaya. All of 
the compounds were separated by using the chromatographic techniques which are thin 
layer chromatography (TLC), column chromatography (CC), high performance liquid 
chromatography (HPLC) and preparative thin layer chromatography (PTLC). Repeated 
chromatographic separation of the hexane crude extract led to the isolation of eight pure 
compounds (Table 3.1). One of the compound, 24(E)- cycloart-24-ene-26-ol-3-one 203, 
is a new compound. 
The structures of the isolated compounds were then elucidated through the 
nuclear magnetic resonance spectroscopy (NMR), 
1
H, 
13
C, DEPT, HSQC, HMBC, 
COSY, mass spectroscopy (MS), ultraviolet spectroscopy (UV) and infrared 
spectroscopy (IR). Majority of compounds were identified based on the spectral 
characteristics depicted in NMR spectra data for complete assignments of carbons and 
protons.  
This chapter discussed herein the analysis and elucidation of eight compounds 
that were isolated from the hexane crude extract of the leaves of Aglaia exima. 
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Table 3.1: Isolated compounds from the hexane crude extract of Aglaia exima  
Name of Compounds Type of 
compound 
Yield 
(mg) 
Percentage of 
compounds from 
hexane crude (%) 
Cycloart-24-ene-3β,26-diol 199 Cycloartane  93.6 0.62 
Vaticinone 200 Cycloartane  6.5 0.04 
Schizandronic acid 201 Cycloartane  16.3 0.11 
Cabraleahydroxylactone 202 Dammarane   2.9 0.02 
24(E)- cycloart-24-ene-26-ol-3-one 203 Cycloartane  19.1 0.13 
24(E)-3β-hydroxycycloart-24-ene-26-al 
204 
Cycloartane  25.6 0.17 
β-sitosterol 205 Sterol 34.2 0.23 
Stigmast-5-ene-28-one 206 Sterol  5.1 0.03 
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Compound A: Cycloart-24-ene-3β,26-diol 199 
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Compound A was isolated as a colorless crystal with a molecular formula of 
C30H50O2 and its melting point was 154-155 
o
C. It was then confirmed by the literature 
spectroscopic data
66
 and X-ray analysis (see Apendix). The optical rotation,  = 
+48.4
o
 (c 0.00062, CH3OH) shows β-configuration of OH at C-3. A molecular ion peak 
at m/z 442 was shown in EI-MS spectra and the UV spectrum showed absorption band 
at 210 nm. Besides, its IR spectrum showed IR absorption at 3400 cm
-1
 suggesting the 
presence of hydroxyl group. 
The 
1
H NMR spectrum in Figure 3.3 showed a characteristic signal of 
cyclopropane methylene, a pair of doublet at upfield region of δ 0.55 (1H, d, J= 4.2Hz) 
and δ 0.33 (1H, d, J= 4.2Hz). There were five methyls assigned by the peak between δ 
0.80 to δ 0.97 and a methyl attached to a double bond emerged as a singlet at more 
downfield position δ 1.59 (3H, s). The 1H NMR also discerned a triplet at δ 5.40 (1H, t, 
J1= 7.1Hz, J2= 13.2Hz) of H-24 indicating the presence of olefinic proton. Besides this, 
spectrum discerned a multiplet and singlet signals at δ 4.00 (H-26) and δ 3.28 (H-3) 
respectively revealed the presence of hydroxyl group in compound A. 
The 
13
C NMR in Figure 3.4 and Figure 3.5 showed the structure was composed 
of six methyls, twelve methylenes, six methines and six quaternary carbons. Peak at δ 
127.1 (C-24) and δ 134.3 (C-25) represented the double bond in the compound A. The 
presence of hydroxyl groups were revealed by the peak at the position of δ 78.8 (C-3) 
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and δ 69.1 (C-26). The carbons of the six methyls gave signals at δ 18.2, δ 18.0, δ 13.6, 
δ 25.4, δ 19.4 and δ 19.3 for C-18, C-21, C-27, C-28, C-29 and C-30 respectively. 
The HMBC correlation confirmed the methyl proton (H-27) has a correlation to 
C-24 and C-25 which were double bond. Besides, the proton (H-26) attached to a 
hydroxyl group correlated with C-24 and C-25. Moreover, the correlation of H-24, the 
olefinic proton to C-22, C-23, C-26, and C-27; H-26 correlated to C-27 confirmed that 
the assignation of side chain. The HMBC correlation showed the correlation of H-2 and 
H-1 with C-3 which is a hydroxyl carbon. In addition, the methylene proton H-19 was 
found having correlation with C-1, C-9, C-10 and C-11 which confirmed its position. 
By comparing the NMR spectral data (Table 3.2) with the literature values
68
, it 
was confirmed that compound A was cycloart-24-ene-3β,26-diol 199. 
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Figure 3.1: Selected HMBC Correlation of Compound A 
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Figure 3.2: ORTEP diagram of Compound A 
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Table 3.2: 
1
H NMR, 
13
C NMR, HMBC Data of Compound A in CDCl3 
Position  δH (ppm) δc (ppm) HMBC (H→C) 
1 1.26 (1H, m) 31.9 3 
 
1.51 (1H, m) 
 
 
2 1.44 (1H, m) 30.3 3 
 
1.74 (1H, m) 
 
 
3 3.28 (1H, m) 78.8 28 
4 - 40.5  
5 1.29 (1H, m) 47.1 - 
6 1.53 (1H, m) 21.1 - 
 
0.78 (1H, m) 
 
 
7 1.24 (1H, m) 28.1 - 
 
1.90 (1H, m) 
 
 
8 1.41 (1H, m) 48.0 - 
9 - 20.0 - 
10 - 26.1 - 
11 1.06 (1H, m) 26.0 - 
 
1.29 (1H, m) 
 
 
12 1.04 (1H, m) 35.5 - 
 
1.36 (1H, m) 
 
 
13 - 45.3 - 
14 - 48.8 - 
15 1.55 (1H, m) 32.9 - 
 
1.34 (1H, m) 
 
 
16 1.58 (1H, m) 26.4 - 
 
1.96 (1H, m) 
 
 
17 1.54 (1H, m) 52.2 - 
18 0.97 (3H, s) 18.2 13,15,17 
19 0.33 (1H, d, J= 4.2 Hz) 29.9 1, 9, 10, 11 
 
0.55 (1H, d, J= 4.2 Hz) 
 
 
20 1.04 (1H, m) 36.0 - 
21 0.89 (3H, d, J= 6.4 Hz) 18.0 17, 22 
22 1.02 (1H, m) 35.9 - 
 
1.23 (1H, m)  
 
 
23 2.05 (1H, m) 24.5 - 
 
1.92 (1H, m) 
 
 
24 5.40 (1H, t, J1= 7.1 Hz, J2= 13.2 Hz) 127.1 22, 23, 26, 27 
25 - 134.3 - 
26 4.00 (2H, s) 69.1 24, 25, 27 
27   1.59 (3H, m) 13.6 24, 25, 26 
28 0.97 (3H, s) 25.4 3 
29 0.81 (3H, s) 14.0 3,5 
30 0.89 (3H, s) 19.3 8, 14, 13 
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Compound B:  Vaticinone 200 
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Compound B was isolated as a white powder with a molecular formula of 
C29H44O2 as a molecular ion peak at m/z 424 was shown in EI-MS. Its optical rotation, 
 = +27.3
o
 (c 0.00011, CH3OH). The UV spectrum revealed an absorption band at 
221 nm and IR spectrum showed IR absorption at 2929, 1707 and 1621 cm
-1
 suggesting 
the presence of alkyl group, ketonic carbonyl and olefinic group respectively. It was 
then further confirmed by literature spectroscopic data
69
.  
The 
1
H NMR spectrum in Figure 3.7 showed characteristic signals for six 
methyl groups at δ 0.91 (Me-30), δ 0.92 (Me-21), δ 1.02 (Me-18), δ 1.05 (Me-28), δ 
1.10 (Me-29), δ 2.26 (Me-26). A pair of characteristic doublet signals at δ 0.56 (1H, d, 
J= 4.2 Hz) and δ 0.77 (1H, d, J= 4.2 Hz) were assigned for methylene group. These 
methylene signals at upfield region indicated compound B to be a cycloartane 
triterpenoid. The presence of a double bond can be shown by the existence of a doublet 
at δ 6.06 (1H, d, J= 15.9 Hz) and multiplet at δ 6.78 (1H, ddd, J1= 6.1 Hz, J2= 8.5 Hz, 
J3= 15.6 Hz) which at the position H-24 and H-23 respectively. 
The 
13
C NMR and DEPT spectra in Figure 3.8 - Figure 3.11 further confirmed 
the existence of two olefinic carbon at δ 132.6 (C-24) and δ 147.7 (C-23) and two 
quaternary carbonyl carbon signals at δ 198.6 (C-25) and δ 216.7 (C-3) were revealed. 
The presence of six methyls in the structure of compound B were shown by the signals 
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at δ 18.2 (Me-18), δ 18.7 (Me-21), δ 27.0 (Me-26), δ 22.3 (Me-28), δ 20.8 (Me-29) and 
δ 19.4 (Me-30) respectively. 
The connection and position of these structures was determined by the HMBC 
correlations (Figure 3.6 and 3.12). The vicinal proton of double bond (H-23) showed 
correlation to a quaternary carbonyl carbon C-25 (δ 198.6) and the quaternary carbonyl 
carbon correlated with methyl proton of H-26 (3H, s). This indicated that the carbonyl 
carbon is in the form of unsaturated ketone by conjugating with the double bond. A pair 
of methyl proton at H-28 (3H, s) and H-29 (3H, s) has correlation to the remaining 
carbonyl carbon C-3 (δ 216.7). Besides, the methylene proton H-19 was found to be 
correlated with C-11 (δ 26.7). 
Compound B was identified by comparison of its spectral data with the literature 
values
67
 thus confirming that compound B was a cycloartane triterpenoid named 
vaticinone 200. 
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Figure 3.6: Key HMBC Correlation of Compound B 
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Table 3.3: 
1
H NMR, 
13
C NMR, HMBC Data of Compound B in CDCl3 
Positio
n  δH (ppm) δC (ppm) HMBC ( H→C ) 
1 1.82 (1H, m) 33.5 - 
 
1.52 (1H, m) 
  2 2.26 (1H, m) 37.5 1, 3 
 
2.69 (1H, td, J1= 7.3 Hz, J2= 13.6 Hz) 
  3 - 216.7 - 
4 - 50.3 - 
5 1.69 (1H, m) 48.5 - 
6 1.54 (2H, m) 21.6 - 
7 1.32 (1H, m) 25.9 - 
 
1.12 (1H, m) 
  8 1.56 (1H, m) 48.0 - 
9 - 21.1 - 
10 - 26.1 - 
11 2.02 (2H, m) 26.7 19 
12 1.61 (2H, m) 32.7 11, 13, 14, 18 
13 - 45.5 - 
14 - 48.9 - 
15 1.32 (2H, m) 35.6 16 
16 1.90 (1H, m) 28.3 - 
 
1.32 (1H, m) 
  17 1.62 (1H, m) 52.3 13, 18 
18 1.02 (3H, s) 18.2 12, 13, 17 
19 0.56 (1H, d, J= 4.2 Hz) 29.6 - 
 
0.77 (1H, d, J= 4.2 Hz) 
  20 1.60 (1H, m) 36.2 13 
21 0.92 (3H, d, J= 5.1 Hz) 18.7 17, 20, 22 
22 2.34 (1H, m) 39.7 - 
 
 
1.94 (1H, m) 
  
23 
6.78 (1H, ddd, J1= 6.1 Hz, J2= 8.5 Hz, J3= 15.6 
Hz) 147.7 25 
24 6.06 (1H, d, J= 15.9 Hz) 132.6 - 
25 - 198.6 - 
26 2.26 (3H, s) 27.0 25 
28 1.05 (3H, s) 22.3 3, 4, 29 
29 1.10 (3H, s) 20.8 3, 4, 28 
30 0.91 (3H, s) 19.4 8, 13, 14 
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Compound C: Schizandronic acid 201 
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Compound C was isolated as colorless needle crystal with melting point 165-
166
o
C and  = +15.4
o
 (c 0.00052, CH2Cl2). The EI-MS spectral showed a 
molecular ion peak at m/z 454 corresponding to the molecular formula of C30H46O3. UV 
spectrum showed an absorption band at 212 nm. IR spectrum showed absorption peak at 
3393, 2934, 1707 cm
-1
 suggesting the presence of hydroxyl, alkyl and carbonyl group 
respectively. 
The 
1
H NMR spectral data in Figure 3.14 showed an upfield pair of doublet 
signal at δ 0.58 (1H, d, J= 5.0 Hz) and δ 0.79 (1H, d, J= 5.0 Hz) for geminal methylene 
group was characteristic of cycloartane triterpenes. Signals for six methyl group 
revealed at δ 0.91 (Me-30), δ 0.93 (Me-21), δ 1.00 (Me-18), δ 1.05 (Me- 29), δ 1.10 
(Me-28), δ 1.85 (Me-27). A triplet at the downfield region of δ 6.90 (1H, t, J1= 7.6 Hz, 
J2= 7.6 Hz) discerned an olefinic proton (H-24). The methyl proton (H-27) neighboring 
with a double bond and carbonyl was shown by a singlet at δ 1.85 (3H, s). 
The 
13
C NMR spectrum in Figure 3.15 - 3.18 showed the presence of six methyl 
groups (C-18, C-21, C-27, C-28, C-29 and C-30), eleven methylenes (C-1, C-2, C-6, C-
7, C-11, C-12, C-15, C-16, C-19, C-22, C-23), five methines (C-5, C-8, C-17, C-20, C-
24), eight quaternary carbon (C-3, C-4, C-9, C-10, C-13, C-14, C-25, C-26). Two out of 
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seven quaternary carbons (C-3 and C-26) were at the position of δ 216.9 and δ 173.1, 
indicating Compound C possesses two keto-groups. 
In the HMBC spectrum (Figure 3.18 and 3.19), the downfield methyl proton H-
27 (δ 1.85) has correlation to C-24 (δ 145.9), C-25 (δ 126.7), C-26 (δ 173.1). The 
olefinic proton H-24 (1H, t, J1= 7.6 Hz, J2= 7.6 Hz) was correlated to C-26. Hence, the 
position of double bond and keto-with a methyl group was confirmed through HMBC 
assignments. The carbonyl carbon (C-3) at the ring A was found to correlate with H-2 
(2H, m) and H-28 (3H, s). The methyl proton H-18 (3H, s) at δ 1.00 correlated to C-12, 
C-13 and C-17 confirmed its position. The spectrum showed that another methyl proton 
H-30 (3H, s) which near to Me-18 has correlation with C-13, C-14 and C-15.  
From the thorough analysis of the spectral data and comparison with the 
literature values
68
, the identity of compound C was established as schizandronic acid 
201. 
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Figure 3.13: Selected HMBC Correlation of Compound C 
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Table 3.4: 
1
H NMR, 
13
C NMR, HMBC Data of Compound C in CDCl3 
Position δH (ppm) δc (ppm) HMBC ( H→C ) 
1 1.56 (1H, m) 33.5 - 
 
1.90 (1H, m) 
  2 2.35 (1H, m) 37.6 1, 3 
 
2.70 (1H, m) 
  3 - 216.9 - 
4 - 50.3 - 
5 1.66 (1H, m) 48.5 - 
6 1.24 (1H, m) 28.2 - 
 
1.90 (1H, m) 
  7 1.57 (1H, m) 21.6 - 
 
1.58 (1H, m) 
  8 1.56 (1H, m) 48.0 - 
9 - 21.1 - 
10 - 26.0 - 
11 1.18 (1H, m) 26.8 9,12,19 
 
2.08 (1H, m) 
  12 1.64 (1H, m) 32.9 11, 13, 14, 18 
 
1.64 (1H, m) 
  13 - 45.5 - 
14 - 48.8 - 
15 1.31 (1H, m) 35.6 - 
 
1.31 (1H, m) 
  16 0.92 (1H, m) 29.7 17 
 
1.28 (1H, m) 
  17 1.61 (1H, m) 52.3 21 
18 1.00 (3H, s) 18.2 12, 13, 17 
19 0.58 (1H, d, J= 5.0 Hz) 29.6 - 
 
0.79 (1H, d, J= 5.0 Hz) 
  20 1.40 (1H, m) 36.0 - 
21 0.93 (3H, d, J= 7.6 Hz) 18.2 17 
22 1.54 (1H, m) 34.8 - 
 
1.18 (1H, m) 
  23 2.10 (1H, m) 26.0 - 
 
2.22 (1H, m) 
  24 6.90 (1H, t, J1= 7.6 Hz, J2= 7.6 Hz) 145.9 26 
25 - 126.7 - 
26 - 173.1 - 
27 1.85 (3H, s) 12.1 24, 25, 26 
28 1.10 (3H, s) 20.9 3, 4, 29 
29 1.05 (3H, s) 22.3 4, 28 
30 0.91 (3H, s) 19.4 13, 14, 15 
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Compound D: Cabraleahydroxylactone 202 
HO
O
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Compound D was isolated as a colorless crystal with a molecular formula 
C27H44O3 based on the molecular ion peak in EI-MS was showed at m/z 416. The 
optical rotation is  = +13.0
o
 (c 0.00023, CH2Cl2). Its melting point was 243-
244
o
C. The assignments of all carbons and protons were achieved by 
1
H and 
13
C NMR 
and comparison of the literature data
71
. It was then further confirmed by x-ray analysis. 
The IR spectrum revealed absorption peak at 3550, 2900, 1760 cm
-1
 suggesting the 
presence of hydroxyl, alkyl and carbonyl group respectively. 
The 
1
H NMR spectral data in Figure 3.21 revealed signals for six methyl groups 
at δ 0.83 (Me-29), δ 0.84 (Me-19), δ 0.89 (Me-30), δ 0.93 (Me-28), δ 0.95 (Me-18) and 
δ 1.35 (Me-21). The methyl signal δ 1.35 (3H, s) (Me-21) was at the most downfield 
compared to other methyl signals. This was due to the oxygen attached on the 
neighboring carbon (C-20). A deshielded broad singlet, most probably belonged to H-3, 
appeared at δ 3.39 (H-3). 
The 
13
C NMR spectrum in Figure 3.22 and 3.23 showed 27 carbon resonances 
comprises of six methyls, ten methylenes, five methines including one oxymethine and 
six quaternary carbons. The signals at δ 15.6, δ 16.1, δ 25.4, δ 28.4, δ 22.2 and δ 16.4 
assigned for C-18, C-19, C-21, C-28, C-29 and C-30 respectively. Besides, the signal at 
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δ 177.0 indicated the carbonyl carbon, C-24 and the signal at δ 76.3 showed the 
existence of hydroxyl carbon, C-3. 
Compound D was confirmed as a dammarane triterpenoid named 
cabraleahydroxylactone 202 by x- ray analysis and the comparison of aforementioned 
1
H and 
13
C spectroscopic data with the reported literature values
69
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.20: ORTEP Diagram of Compound D 
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Table 3.5: 
1
H NMR and 
13
C NMR Data of Compound D in CDCl3  
Position  δH (ppm) δc (ppm) 
1 1.26 (1H, m) 33.7 
 
1.35 (1H, m) 
 2 1.55 (1H, m) 25.4 
 
1.91 (1H, m) 
 3 3.39 (1H, s) 76.3 
4 - 37.7 
5 1.26 (1H, m) 49.4 
6 1.41 (1H, m) 18.3 
7 1.23 (1H, m) 35.2 
 
1.56 (1H, m) 
 8 - 50.4 
9 1.44 (1H, m) 50.4 
10 - 37.3 
11 1.19 (1H, m) 26.9 
 
1.72 (1H, m) 
 12 1.20 (1H, m) 21.3 
 
1.55 (1H, m) 
 13 1.71 (1H, m) 43.2 
14 - 40.6 
15 1.11 (1H, m) 31.2 
 
1.47 (1H, m) 
 16 1.26 (1H, m) 25.1 
 
1.81 (1H, m) 
 17 1.97 (1H, m) 49.6 
18 0.95 (3H, s) 15.6 
19 0.84 (3H, s) 16.1 
20 - 90.4 
21 1.35 (3H, s) 25.4 
22 1.94 (1H, m) 31.2 
 
2.12 (1H, m) 
 23 2.53 (1H, ddd, J1= 4.6 Hz, J2= 10.0 Hz, J3= 17.2 Hz) 29.3 
 
2.62 (1H, ddd, J1= 9.5 Hz, J2= 10.3 Hz, J3= 18.1 Hz) 
 24 - 177.0 
25 - 
 26 - 
 27 - 
 28 0.93 (3H, s) 28.4 
29 0.83 (3H, s) 22.2 
30 0.89 (3H, s) 16.4 
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Compound E: 24(E)-cycloart-24-ene-26-ol-3-one 203 
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Compound E, was obtained as colorless amorphous solid,  +29.7
o
 (c 
0.00209, CH2Cl2). The ESI-TOF spectrum showed an [M+Na]
+
 pseudomolecular ion 
peak at m/z 463.3813 (calcd 463.3678) which corresponded to the molecular formula of 
C30H48O2. The IR spectrum showed absorption peaks at 3445, 2942, 1705cm
-1
 
suggesting the presence of hydroxyl, alkyl and carbonyl groups respectively.  
The cycloartane nature of compound E was deduced by the appearance of a pair 
of very shielded doublets at δ 0.58 and 0.79 (J = 4.4 Hz).  The olefinic proton (H-24) 
resonated as a broad triplet at δ 5.36 (J= 7.1 Hz). ). In addition, the oxymethylene 
protons which were attached to C-26 appeared as a broad singlet at δ 3.94. The 13C 
NMR and DEPT spectra showed peaks corresponding to thirty carbons; six methyl, 
twelve methylene, five methine, and seven quaternary carbons. The peak at δ 216.7 is 
assignable to the ketonic carbonyl, C-3. In addition, the signals of the double bond 
carbons (C-24, C-25) appeared at δ 127.0 and δ 134.3 respectively. The methylene 
carbon C-26 of the side chain resonated downfield at δ 69.0 since it is attached to a 
hydroxyl group.  
The HMBC spectrum showed correlations of H-24 with C-26 and C-27, H-26 
with C-24, C-25 and C-27 thus confirming the position of the double bond at C-24 and 
C-25 respectively. Furthermore, the location of the hydroxyl group on C-26 was also 
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established by the HMBC correlations of H2-26 with C-24, 25 and C-27. Thorough 
analysis of the DEPT, COSY, HSQC and HMBC spectra allowed the complete 
assignment of all protons and carbons (Table 1).  
The NOESY experiment showed a correlation between H-24 and H2-26 thus 
suggesting that the C-24-C-25 double bond assumes an E-configuration. Therefore, 
compound E was elucidated as 24(E)-cycloart-24-ene-26-ol-3-one 203.  
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Figure 3.24: HMBC correlation of Compound E 
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Table 3.6: 
1
H NMR, 
13
C NMR and HMBC Data of Compound E in CDCl3 
Position δH (ppm) δC (ppm) HMBC (H→C) 
1 1.48 (1H, m) 33.4 10, 19 
 1.78 (IH, m)   
2 2.30 (1H, ddd, J1=4.1 Hz, 
J2 =8.2 Hz, J3 = 14.4 Hz)  
37.4 1, 3 
 2.70 (1H, dt, J1= 6.4 Hz, 
J2= 14.2 Hz) 
  
3 - 216.7 - 
4 - 50.2 - 
5 1.52 (1H, m) 48.4 - 
6 1.50 (2H, m) 21.5 5 
7 1.22 (1H, m) 28.1 8 
 1.84 (1H, m)   
8 1.64 (1H, m) 47.8 - 
9 - 21.1 - 
10 - 25.9 - 
11 1.10 (1H, m) 26.7 8, 9, 12, 13, 19 
 1.98 (1H, m)   
12 1.60 (2H, m) 32.8 11, 13, 14, 17, 18,  
13 - 45.3 - 
14 - 48.7 - 
15 1.02 (2H, m) 35.9 - 
16 1.86 (1H, m) 24.5 14 
 2.02 (1H, m)   
17 - 52.2 - 
18 1.00 (3H, s) 18.1 12, 13, 14, 17 
19 0.58 (1H, d, J= 4.26 Hz) 29.5 1, 9, 10 
 0.79 (1H, d, J= 4.26 Hz)   
20 1.02 (1H, m) 35.9 - 
21 0.91 (3H, d, J= 6.1Hz) 18.2 17, 22 
22 1.24 (2H, m) 35.5 - 
23 1.08 (1H, m) 25.8 - 
 1.30 (1H, m)   
24 5.36 (1H, t, J1= 7.1 Hz, 
J2= 14.1 Hz) 
127.0 26, 27 
25 - 134.3 - 
26 3.94 (2H, s) 69.0 24, 25, 27 
27 1.68 (3H, s) 13.6 24, 26 
28 1.05 (3H, s) 22.2 3, 4 
29 
30 
1.10 (3H, s) 
0.91 (3H, s) 
20.7 
19.3 
3, 4 
8, 13, 14 
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Compound F:  24(E)-3β-hydroxycycloart-24-ene-26-al 204 
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Compound F was isolated as a pale yellow gel with molecular formula C30H48O2 
(EIMS) as the existence of a molecular peak at m/z 440 in EI-MS spectrum. The optical 
rotation is  = +33.1
o
 (c 0.0016, CH2Cl2). An absorption band at 220 nm was 
shown in the UV spectrum. The IR spectrum showed absorption peaks at 3429, 2937, 
1689 cm
-1
 suggesting the presence of hydroxyl, alkyl and carbonyl group respectively. 
The
 1
H NMR spectrum of compound F in Figure 3.34 showed the presence of 
six methyls; δ 0.81 (Me- 28), δ 0.90 (Me- 30), δ 0.93 (Me- 21), δ 0.97 (Me- 29), δ 0.97 
(Me- 18) and δ 1.75 (Me- 27). The doublet at δ 0.93 (3H, d, J= 2.2 Hz) indicated it was 
a secondary methyl (Me- 21). Besides, a pair of doublets at the upfield region, δ 0.34 
(1H, d, J= 4.2 Hz) and δ 0.56 (1H, d, J= 4.2 Hz) showed the characteristic of non-
equivalent protons of a cyclopropyl methylene group (H-19)
70
. In addition, signals due 
to a methine proton geminal to a hydroxyl  (δ 3.29, H-3), methine proton to a double 
bond (δ 6.50, H-24) and methine proton geminal to a carbonyl were observed. A singlet 
in the downfield region at δ 9.39 (1H, s) indicated the presence of an aldehyde proton, 
The 
13
C NMR and DEPT spectra (Figure 3.35- Figure 3.38) showed 30 signals 
consisting of six methyls (C-18, C-21, C-27, C-28, C-29, C-30), eleven methylenes (C-1, 
C-2, C-6, C-7, C-11, C-12, C-15, C-16, C-19, C-22, C-23), seven methines (C-3, C-5, 
C-8, C-17, C-20, C-24, C-26), six quaternary (C-4, C-9, C-10, C-13, C-14, C-25) carbon 
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atoms. Signals at δ 18.2, δ 18.2, δ 9.3, δ 14.1, δ 25.5, δ 19.4 corresponded to the six 
methyls, C-18, C-21, C-27, C-28, C-29 and C-30 respectively. In the 
13
C NMR 
spectrum, the signal of the C-26 carbonyl appeared at δ 195.6 and signal at δ 77.4 
revealed the existence of the hydroxyl at C-3. 
The HMBC correlations H-27/ C-24, C-25, C-26 and H-26/ C-24, C-25, C-27 
indicated that the C-26 aldehyde is neighbouring to a methyl (H-27) and a double bond 
(H-24, H-25). In addition, the correlations H-2, H-28, H-29/ C-3 showed that the 
hydroxyl is located at the fused ring A. 
Thorough study of the spectral data and comparison with the literature 
values
71,72
 established that Compound F is the known cycloartane triterpenoid,  24(E)-
3β-hydroxy-cycloart-24-ene-26-al 204. 
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Figure 3.33: Selected HMBC correlation of Compound F 
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Table 3.7: 
1
H NMR, 
13
C NMR and HMBC Data of Compound F in CDCl3 
Position δH (ppm) δC (ppm) HMBC (H→C) 
1 1.22 (1H, m) 32.1 10 
 1.24 (1H, m)   
2 1.53 (1H, m) 30.4 1, 3, 4, 10 
 1.74 (1H, m)   
3 3.29 (1H, m) 77.4 - 
4 - 40.6 - 
5 1.30 (1H, m) 47.2 4, 28 
6 1.54 (1H, m) 21.2 - 
 1.60 (1H, m)   
7 1.06 (1H, m) 26.1 8 
 1.34 (1H, m)   
8 1.51 (1H, m) 48.1 9, 10, 14, 15, 19 
9 - 20.0 - 
10 - 26.1 - 
11 1.90 (1H, m) 26.5 8, 9, 12, 13, 19 
 2.02 (1H, m)   
12 1.61 (1H, m) 33.0 13, 18 
13 - 45.4 - 
14 - 48.9 - 
15 1.28 (2H, m) 35.6 16, 30 
16 1.26 (1H, m) 28.3 - 
 1.88 (1H, m)   
17 1.59 (1H, m) 52.3 12 
18 0.97 (3H, s) 18.2 12, 17 
19 0.56 (1H, d, J= 4.2 Hz) 30.0 1, 9, 10, 11 
 0.34 (1H, d, J= 4.2 Hz)   
20 1.40 (1H, m) 36.1 - 
21 0.93 (3H, d, J= 2.2 Hz) 18.2 17 
22 - 34.8 - 
23 2.24 (1H, m) 26.1 22, 24, 25 
 2.40 (1H, m)   
24 6.50 (1H, td, J1= 1.2 Hz, J2= 7.8 Hz) 155.8 22, 23, 26 
25 - 139.2 - 
26 9.39 (1H, s) 195.6 24, 25, 27 
27 1.75 (3H, s) 9.3 24, 25, 26 
28 0.81 (3H, s) 14.1 3, 4, 5, 29 
29 0.97 (3H, s) 25.5 3, 4, 5, 28 
30 0.90 (3H, s) 19.4 8, 14, 15 
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Compound G: β-Sitosterol 205 
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Compound G was isolated as a colorless crystal with melting point 136-136
o
C 
and the molecular ion peak at m/z 414 in EIMS spectrum suggested that the compound 
molecular formula was C29H50O. Its optical rotation,  = -33.3
o
 (c 0.00209, 
CH2Cl2). An absorption band at 211 nm was revealed in the UV spectrum. The 
absorption peaks at 3418, 2936, 1644 and 1463 cm
-1
 displayed in IR spectrum showed 
the presence of hydroxyl, alkyl, carbonyl and olefinic group respectively. 
The 
1
H NMR spectrum of compound G in Figure 3.41 revealed the presence of 
six methyls at δ 0.68 (Me- 18), δ 0.79 (Me- 26), δ 0.85 (Me-27, Me- 29), δ 0.91 (Me- 
21), δ 1.00 (Me- 19). Among the signals, there was a doublet at δ 0.91 (3H, d, J= 8.1 Hz) 
assigned to Me-21. A multiplet at δ 3.48 (1H, m) due to a methine proton (H-3) geminal 
to hydroxyl was observed. The existence of a double bond is showed by a signal at 
downfield region, δ 5.34 (1H, d, J= 18.3 Hz).  
The 
13
C  NMR in Figure 3.42 - 3.43 showed a total of 29 carbons consisting of 
six methyls (C-18, C-19, C-21, C-26, C-27, C-29), eleven methylenes (C-1, C-2, C-4, 
C-7,C-11, C-12, C-15, C-16, C-22, C-23, C-28), nine methines (C-3, C-6, C-8, C-9, C-
14, C-17, C-20, C-24, C-25) and three quaternary (C-5, C-10, C-13) carbon atoms. 
Signal appeared at δ 121.8 and δ 140.8 revealed that compound G possessed a double 
bond in the compound. 
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The HMBC correlation H-6/ C-4, C-7, C-8, C-10 suggested that the position of 
the double bond in ring B. In addition, the correlations of H-1, H-2, H-4/ C-3 showed 
that the hydroxyl was located at C-3 of ring A.  
Compound G was confirmed as β-Sitosterol 205 by the comparison of 
aforementioned 
1
H and 
13
C spectroscopic data with the reported literature values
73,74,75
. 
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Figure 3.40: HMBC Correlation of Compound G 
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Table 3.8: 
1
H NMR and 
13
C NMR HMBC Data of Compound G in CDCl3 
Position δH (ppm) δC (ppm) HMBC (H→C) 
1 1.82 (1H, m) 37.4 3, 10 
 1.06 (1H, m)   
2 1.80 (2H, m) 31.7 3 
3 3.48 (1H, m) 71.9 1, 2 
4 2.25 (1H, m) 42.4 2, 3, 5, 6, 10 
5 - 140.8 - 
6 5.34 (1H, d, J= 18.3 Hz) 121.8 4, 7, 8, 10 
7 1.47 (1H, m) 32.0 5, 6, 14 
 1.94 (1H, m)   
8 1.47 (1H, m) 32.0 7, 11, 13, 14 
9 - 50.2 11 
10 - 36.6 - 
11 1.02 (1H, m) 21.2 12 
 1.46 (1H, m)   
12 1.14 (1H, m) 28.3 18 
 1.98 (1H, m)   
13 - 42.4 - 
14 0.98 (1H, m) 56.9 13, 17 
15 1.03 (1H, m) 24.4 8, 16 
 1.56 (1H, m)   
16 1.24 (1H, m) 39.9 - 
 1.80 (1H, m)   
17 1.10 (1H, m) 56.1 18 
18 0.68 (3H, s) 11.9 13, 14, 17 
19 1.00 (3H, s) 19.5 1, 5, 9, 10 
20 1.32 (1H, m) 36.2 23 
21 0.91 (3H, d, J=8.1 Hz) 18.9 17, 20 
22 1.14 (2H, m) 26.2 23, 24 
23 0.99 (1H, m) 34.0 22, 28 
 1.30 (1H, m)   
24 0.91 (3H, d, J= 8.1 Hz) 45.9 22 
25 1.64 (1H, m) 29.2 - 
26 0.79 (3H, s) 19.1 25, 27 
27 0.85 (3H, s) 19.9 25, 26 
28 1.03 (1H, m) 23.2 25, 29 
 1.22 (1H, m)   
29 0.85 (3H, d, J= 1.7 Hz) 12.1 28 
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Compound H: Stigmast-5-ene-28-one 206  
 
HO
18
3
4
5 7
810
9
11
12
14
13
15
16
17
20
21 22
25
27
2
1
23
19
O
6
24
28
26
29
 
 
Compound H was isolated as a colorless crystal with melting point 147-148
o
C 
and the EI-MS spectral showed a molecular ion peak at m/z 428 corresponding to the 
molecular formula of C29H48O2. In the UV spectrum, an absorption band at 208 nm was 
observed. Its IR spectrum showed IR absorption at 3419 cm
-1
 suggesting the presence of 
hydroxyl group and the absorption bands for acetyl appeared at 1713, 1456, 1374 cm
-1
. 
The 
1
H NMR spectrum of compound H in Figure 3.48 showed the presence of 
six methyl signals at the position δ 0.70 (Me-18), δ 0.87 (Me-26), δ 0.89 (Me-27), δ 
0.91 (Me-21), δ 1.00 (Me-19), δ 2.09 (Me-29). A doublet at δ 0.91 (3H, d, J= 2.0 Hz) 
showed the methyl proton (H-21) at the side chain. Besides, additional doublet at δ 0.89 
(3H, m) indicated another methyl proton (H-27).  A singlet at δ 2.09 (3H, s) indicated 
another methyl proton attached to a carbonyl carbon. A doublet at δ 5.32 (1H, d, J= 6.9 
Hz) discerned a methine proton (H-6) geminal to a double bond. In addition, a multiplet 
at δ 3.50 (1H, m) of methine proton (H-3) attach to the hydroxyl at the ring.  
The 
13
C NMR data in Figure 3.49 - 3.50 revealed a total of 29 carbons comprises 
of six methyls (C-18, C-19, C-21, C-26, C-27, C-29), ten methylenes (C-1, C-2, C-4, C-
7, C-11, C-12, C-15, C-16, C-22, C-23), nine methines (C-3, C-6, C-8, C-9, C-14, C-17, 
C-20, C-24, C-25) and four quaternary carbons (C-5, C-10, C-13, C-28). Signal 
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appeared at δ 213.5 showed that the existence of ketone moiety (C-28) and signal at δ 
121.8 and δ 140.8 indicated that the compound possess a double bond (C-6, C-5). 
The HMBC correlations H-29/ C-24, 28 and H-25/ C-24 confirmed that the 
position of the ketonic carbonyl at side chain. The HMBC correlation H-4/ C-3, 5, 6 
confirmed the position of the double bond in ring B. 
Compound H are being reported for the first time as naturally occurring 
compounds. Accordingly, Compound H was established as stigmast-5-ene-28-one 206 
on the basis of spectroscopic methods and X-ray analysis (Figure 3.47). 
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Figure 3.46: Selected HMBC correlations of Compound H 
 
 
Figure 3.47: ORTEP Diagram of Compound H 
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Table 3.9: 
1
H NMR, 
13
C NMR and HMBC Data of Compound H in CDCl3 
Position δH (ppm) δC (ppm) HMBC (H→C) 
1 1.06 (1H, m) 
1.79 (1H, m) 
37.3 - 
2 1.80 (2H, m) 31.7 - 
3 3.50 (1H, m) 71.9 - 
4 2.21 (1H, m) 42.4 3, 5, 6 
5 - 140.8 - 
6 5.32 (1H, d, J= 6.9 
Hz) 
121.8 4, 7 
7 1.44 (1H, m) 
1.92 (1H, m) 
32.0 - 
8 1.44 (1H, m) 32.0 - 
9 0.89 (1H, m) 50.1 - 
10 - 36.5 - 
11 1.40 (1H, m) 
1.44 (1H, m) 
21.1 - 
12 1.10 (1H, m) 
1.96 (1H, m) 
39.8 - 
13 - 42.4 - 
14 0.96 (1H, m) 55.9 - 
15 0.98 (1H, m) 
1.52 (1H, m) 
24.3 - 
16 1.14 (1H, m) 
1.74 (1H, m) 
28.2 - 
17 1.04 (1H, m) 55.8 - 
18 0.70 (3H, s) 11.9 12, 13, 14, 17 
19 1.00 (3H, s) 20.1 1, 9, 10 
20 1.32 (1H, m) 35.9 - 
21 0.91 (3H, d, J= 2.0 
Hz) 
18.5 17, 22 
22 0.88 (1H, m) 
1.20 (1H, m) 
33.9 21 
23 1.32 (1H, m) 
1.54 (1H, m) 
25.4 - 
24 2.11 (1H, d, J= 6.9 
Hz) 
60.6 - 
25 1.78 (1H, m) 30.2 24 
26 0.87 (3H, d, J= 2.2 
Hz) 
21.3 27 
27 0.89 (3H, d, J= 2.2 
Hz) 
20.1 24, 25, 26 
28 - 213.5 - 
29 2.09 (3H,s) 30.0 24, 28 
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4.1       CYTOTOXIC ACTIVITY  
 Cytotoxic assay are widely used particulary in the natural products field. It 
measures the effect of a drug on the basic functions of cells which are common to all 
cells by assessing cellular damage. There are a few types of cytotoxic assay useful in 
monitoring the cyctotoxicity of natural products
76 , 77
. In this study, MTT or MTS 
colorimetric assay is used to measure the cytotoxicity of all compounds isolated from 
Aglaia exima against eight cell lines. This MTT assay is a quantitative test to measure 
the growth or death rate of cells. It is also a key tool for the development of natural 
products due to its reliable detection of anticancer
78
. Hereunder the materials used, 
procedures and results of the cytotoxic assay for the eight compounds. 
Cytotoxicity of the compounds were evaluated against a panel of eight cancer 
cell lines; lung (A549), prostate (DU-145), skin (SK-MEL-5), pancreatic (BxPC-3), 
liver (Hep G2), colon (HT-29), breast (MCF-7) and (MDA-MB-231). These cancer cell 
lines were chosen from the National Cancer Institute (NCI) list of 60 cancer cell lines 
for drug screening and drug treatment conditions and were done according to the NCI 
recommendations (Boyd, 1995). 
4.2       RESULTS OF CYTOTOXIC ACTIVITY 
According to the results in Table 4.1, it was concluded that colon (HT-29) 
cancer cell lineS was found to be very susceptible towards 24(E)-cycloart-24-ene-26-ol-
3-one 203 with IC50 values of 11.48 μM. Meanwhile, 24(E)-cycloart-24-ene-26-ol-3-
one 203 revealed moderate activity to skin (SK-MEL-5) and breast (MCF-7) cell lines. 
Cycloart-24-ene-3β,26-diol 199 shows moderate effect against liver (Hep G2) and colon 
(HT-29), weak against lung (A549), skin (SK-MEL-5), breast (MCF-7) and (MDA-MB-
231). Vaticinone 200 revealed moderate inhibitory effect towards colon (HT-29) and 
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weak towards skin (SK-MEL-5). At last, 24(E)-3β-hydroxycycloart-24-ene-26-al 204 
has moderate effect against breast (MDA-MB-231) and weak against skin (SK-MEL-5). 
schizandronic acid 201, cabraleahydroxylactone 202, β-sitosterol 205 and stigmast-5-
ene-28-one 206 exhibited no significant inhibitory effects with IC50 values over 200 μM. 
As comparing to the drug standard, Cisplatin, the two cycloartane-type 
triterpenoids, Cycloart-24-ene-3β,26-diol 199 and 24(E)-3β-hydroxycycloart-24-ene-26-
al 204 have stronger inhibitory effect towards breast (MDA-MB-231). The new 
cycloartane-type triterpenoid, 24(E)-cycloart-24-ene-26-ol-3-one 203, showed stronger 
affect than the drug standard, Cisplatin, against the colon (HT-29) and breast (MCF-7) 
cell lines. 
The author has conducted a simple structure-activity relationship study on 
compounds cycloart-24-ene-3β,26-diol 199 and 24(E)-cycloart-24-ene-26-ol-3-one 203. 
It was observed that the structure of these two compounds showed small difference 
where the hydroxyl group at position C-3 replaced by carbonyl group. However, the 
cytotoxic activity of these compounds revealed large difference against colon (HT-29) 
cell line with 99.31 μM and 11.48 μM. Thus, this indicated that the carbonyl group at 
the position C-3 may be responsible for the strong cytotoxic activity towards colon (HT-
29) cell line. 
In this study, the author has proposed the biosynthesis relationship between all 
the isolated cycloartane triterpenoid in scheme 4.1. Besides, the proposed relationship 
between the sterols were also depicted in scheme 4.2. 
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Scheme 4.1 Proposed biosynthesis relationship of compounds 199, 200, 201, 203 and 204 
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Scheme 4.2 Proposed biosynthesis pathway of compound 202 
This study has shown that Aglaia exima possess interesting compounds that may 
be subjected to further studies such as hemisynthesis and apoptotic studies.
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Table 4.2: Cytotoxicity of Eight Compounds for Eight Cancel Cell Lines
a
  
Name of Compounds Lung 
(A54
9) 
Prosta
te  
(DU-
145) 
Skin 
(SK-
MEL
-5) 
Pancre
atic 
(BxPC
-3) 
Liver 
(Hep 
G2) 
Colo
n 
(HT-
29) 
Breas
t 
(MC
F-7) 
Brea
st 
(MD
A-
MB-
231) 
Cycloart-24-ene-
3β,26-diol 199 
172.3
5 
- 157.8
1 
- 75.10 99.3
1 
127.7
3 
195.
23 
Vaticinone 200 - - 105.7
3 
- - 96.7
8 
- - 
Schizandronic acid 
201 
- - - - - - - - 
Cabraleahydroxylact
one 202 
- - - - - - - - 
24(E)-cycloart-24-
ene-26-ol-3-one 203 
- - 96.58 - - 11.4
8 
86.20 - 
24(E)-3β-
hydroxycycloart-24-
ene-26-al 204 
- - 117.7
7 
- - - - 94.3
8 
β- sitosterol 205 - - - - - - - - 
Stigmast-5-ene-28-
one 206 
- - - - - - - - 
a 
Results are expressed as IC50 values in μM . Blank indicates IC50 more than 200 μM  
Table 4.2: Cytotoxicity of Drug Standards against Eight Cancel Cell Lines 
(Mean ± SD, n=3) Drug standards 
Cisplatin Vinblastine 
Lung (A549) 36.17 ± 3.00 µM 29.01 ±  6.46 µM 
Prostate (DU-145) 12.54 ± 0.50 µM 4.75 ± 1.13 µM 
Skin (SK-MEL-5) 68.86 ± 1.13 µM 1.71 ± 0.24 µM 
Pancreatic (BxPC-3) 22.10 ± 0.31 µM 2.03 ± 1.05 µM 
Liver (Hep G2) 15.20 ± 1.04 µM 0.35 ± 0.41 µM 
Colon (HT-29) 70.19 ± 2.21 µM 0.98 ± 0.33 µM 
Breast (MCF-7) 90.11 ± 2.11 µM 28.11 ± 3.20 µM 
Breast (MDA-MB-231) 306.73 ± 3.45 µM 35.32 ± 3.42 µM 
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5.1       CONCLUSION  
The chemical study on the hexane extract from the leaves of Aglaia exima was 
conducted and repeated chromatographic separation resulted in the isolation of one new 
compound;  24(E)-cycloart-24-ene-26-ol-3-one 203, and seven known triterpenes and 
steroids; cycloart-24-ene-3β,26-diol 199, vaticinone 200, schizandronic acid 201, 
cabraleahydroxylactone 202, 24(E)-3β-hydroxy-cycloart-24-ene-26-al 204, β-sitosterol 
205 and stigmast-5-ene-28-one 206. The elucidation of structures was confirmed 
through spectroscopic methods: NMR (nuclear magnetic resonance), MS (mass 
spectrometry), UV (ultraviolet), IR and X-ray analysis. 
This particular Aglaia species (Aglaia exima) has not been studied before. 
However, there were chemical studies done on other Aglaia species and various types of 
triterpenoids were found in the plant of Aglaia species. Table 5.1 below shows the 
summary of the different types of triterpenoids found in Aglaia species. In this study, on 
Aglaia exima, three different types of triterpenoids (cycloartane, dammaranes and 
steroids) were found from the hexane crude of leaves. Of the eight pure compounds, 
four were obtained as colorless crystals which are cycloart-24-ene-3β,26-diol 199, 
schizandronic acid 201, cabraleahydroxylactone 202, β-sitosterol 205 and stigmast-5-
ene-28-one 206. 
From this study, the author has observed that the major compounds isolated 
from Aglaia exima were cycloartane-type triterpenoids which are similar to the findings 
from A. forbesii, A. argentea, A. lawii, A. roxburghiana and A. harmsiana (Table 5.1).  
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In addition, the majority of cycloartane-type triterpenoids isolated from the 
leaves of Aglaia exima were found to be cytotoxic against eight cancer cell lines; lung 
(A549), prostate (DU-145), skin (SK-MEL-5), pancreatic (BxPC-3), liver (Hep G2), 
colon (HT-29), breast (MCF-7) and (MDA-MB-231). The cycloart-24-ene-3-one-26-ol 
203 was found to be very strongly active against colon (HT-29) cell line with IC50 
values of 11.48 μM.  No inhibitory effect was observed for the sterol and dammarane 
triterpenoids isolated from Aglaia exima (Chapter 4).  
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6.1       GENERAL 
Solvents (hexane, dichloromethane, methanol) used for the bulk extraction are 
industrial grade and all of these solvents were distilled before use.  
Shimazu UV-160A ultraviolet-visible spectrometer was used to obtain UV 
spectra with methanol as a solvent. 
Infra- red spectra were obtained by using the Perkin Elmer 1600 Series FT-NMR, 
chloroform was used as solvent. 
The 
1
H-NMR spectra were taken by dissolving the sample in deuterated 
chloroform in the JEOL JNM-LA 400 FT-NMR system. Mostly of 13C, DEPT, HSQC 
and HMBC spectra were obtained from JEOL ECA 400. Chemical shifts is given in 
ppm on δ scale. 
Mass spectra were carried out by Shimadzu Liquid Chromatograph Mass 
Spectrometer.  
Silica gel 60 (0.063-0.200 mm) and silica gel 60 (0.040-0.063 mm) were used 
for column chromatography. Aluminium supported silica gel 60 F254 plates was used 
for TLC. The spots on the TLC were visualized under ultra-violet (UV) light (254 nm 
and 365 nm) followed with spraying by vanillin reagent. The vanilin reagent was 
prepared by diluting 10 mL of sulphuric acid with 90 mL of water in 100 mL ethanol 
and followed by adding 10 mg vanillin powder. 
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6.2       CYTOTOXIC ASSAY MATERIALS 
Human cancer cell lines were obtained from American Type Culture Collection 
(ATCC) (Manassas, VA, USA). Dulbecco’s modified Eagle’s medium (DMEM), 100 
mM non-essential amino acids, phosphate buffer solution (pH 7.2), 50 µg/ml 
gentamycin and 2.5 µg/ml amphotericin B were purchased from Invitrogen Corporation 
(Carlsbad, CA, USA). 200 mM L-glutamine, foetal bovine serum, 0.25% trypsin-EDTA, 
dimethyl sulphoxide (DMSO), cisplatin and vinblastine sulphate were purchased from 
Sigma–Aldrich (St. Louis, MO, USA). MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxy-methoxyphenyl)-2-(4-sulphophenyl)-2H-tetrazolium, inner salt]  assay kit 
(CellTiter 96® AQueous One Solution) was obtained from Promega (Madison, WI, USA).  
6.3       PLANT MATERIAL 
The leaves of Aglaia exima was collected from Hutan Simpanan Kg. Kepayang, 
Pahang, Malaysia on November 1997. Voucher specimen (KL 4762) has been deposited 
at the Herbarium of Department of Chemistry, University of Malaya, Kuala Lumpur, 
Malaysia.  
6.4       EXTRACTION AND ISOLATION OF PLANT MATERIAL 
Dried ground leaves (1 kg) of Aglaia exima were extracted exhaustively with 
hexane at room temperature for 4 days and then filter. The solution was decanted and 
then evaporated to leave a residue of 25 g hexane extracts. The extraction method 
depicted above was continued with dichloromethane and methanol. A yield of extracts 
for hexane (25 g), dichloromethane (64 g) and methanol (106 g) were obtained. The 
dichloromethane and methanol crude were kept for future use.  
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Of the 25 g of hexane crude, 15 g of the hexane crude was fractionated by using 
column chromatography over silica gel using a gradient mixture of hexane and ethyl 
acetate as eluent. Methanol was used at the end of separation in the purpose of flushing 
the column. Amount of silica used was in the ratio of 1 g mass of crude to 30 g silica gel 
(1:30). A total of 123 fractions were obtained from the rough separation of column 
chromatography. The fractions collected were then grouped into a series of fractions 
according to the Rf value and stains after monitoring with thin layer chromatography 
(TLC). Fraction tested on TLC with the same Rf value and color of spot was combined 
as a group. Each of the group were then separated and purified by repeated column 
chromatography (solvent mixture of hexane and ethyl acetate) and high pressure liquid 
chromatography (HPLC) until a single spot on TLC was obtained.  From the 123 
fractions, Fr. 54 was obtained as a colorless crystal 205 (34.2 mg). Meanwhile, further 
isolation of Fr. 67 (ethyl acetate-hexane 86:14, 0.72 g) in CC with silica gel (22 g) give 
200 (6.5 mg), 203 (4.8 mg), 204 (25.6 mg) and 206 (5.1 mg). Besides, Fr. 94- Fr. 100 
(ethyl acetate- hexane 60:40 50:50 20:80, 1.5398 g) were combined and further isolated 
by CC on silica gel (46 g) to furnish 201 (16.3 mg) and 202 (2.9 mg). Of 123 fractions, 
Fr. 92 was collected as a green crystal which was then recrystallized by ethyl acetate to 
obtain a colorless crystal, 199 (93.6 mg).  
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Table 6.1: Chromatographic Results and Yield of Compounds from the Leaves of 
Aglaia exima 
Solvent System for 
Column 
Chromatography 
(Hexane: Ethyl Acetate) 
Compounds Yield (mg) 
90 : 10 β-Sitosterol 205 34.2 
86 : 14 Vaticinone 200 
Cycloart-24-ene-3-one-26-ol 203 
24(E)-3β-hydroxycycloart-24-
ene-26-al 204 
Stigmast-5-ene-28-one 206 
6.5 
19.1 
25.6 
5.1 
70 : 30 Cycloart-24-ene-3β,26-diol 199 93.6 
60 : 40 Schizandronic Acid 201 16.3 
50 : 50 Cabraleahydroxylactone 202 2.9 
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6.5       METHOD OF CYTOTOXIC ASSAY 
Cell lines were cultured in DMEM media supplemented with 2 mM L-glutamine, 
10% foetal bovine serum, 50 µg/mL gentamycin and 2.5 µg/mL amphotericin B, 
maintained in a 37 ºC humid atmosphere of 5% CO2 cell incubator. Samples and drug 
standards (cisplatin and vinblastine sulphate) were dissolved in DMSO and immediately 
diluted with DMEM media to yield a final DMSO concentration of less than 0.5% v/v.  
Cells were plated into 96-well microplates at 5,000–10,000 cells per well and 
maintained in the cell incubator for 24 hour. Then, 100 µL of samples were introduced 
in triplicates to a final concentration of 15–200 µM, with the exception of sample 5 that 
was further diluted down to 4 µM in BxPC-3 and HT-29 cell lines. Drug standards were 
also introduced to a final concentration of 0.03 - 2000 µM (cisplatin) and 0.002 - 100 
µM (vinblastine sulphate). Cells were further incubated for 48 hours and then, cell 
viability was determined according to the manufacturer protocol of a commercial MTS 
assay kit (CellTiter 96 AQueous® One Solution, Promega). Culture media were carefully 
refreshed with 100 µL of DMEM media, followed by 20 µL per well of MTS reagent. 
Microplates were returned to the incubator for 1 to 2 hours and absorbance of the 
formazan product was read on a microplate reader at 490nm with 690nm as the 
background wavelength (Infinite 200, Tecan, Männedorf, Swizerland). IC50 of samples 
and drug standards were determined using dose-response curves in Prism 5.02 software 
(GraphPad Software Inc., La Jolla, CA, USA). 
 
 
 
Experimental                                                                                                        Chapter 6 
128 
 
6.6       GENERAL SPECTRAL DATA OF ISOLATED COMPOUNDS    
OH
18
3
4
5 7
810
9
11
12
14
13
15
16
17
19
20
21 22 24
29
6
2
1
23
28
30
27
25
HO
26
                                            
Cycloart-24-ene-3β,26-diol  199   
Molecular formula                    
UV λmax nm                            
IR υmax                                    
Mass Spectrum m/z                   
1
H-NMR                                   
13
C-NMR                                   
: Colorless Crystal  
: C30H50O2 
: 210 
: 3400, 3042 
: 442 
: Refer Table 3.2 
: Refer Table 3.2 
 
 
O
18
3
4
5 7
810
9
11
12
14
13
15
16
17
19
20
21 22 24
29
6
2
1
23
28
30
26
25
O
 
Vaticinone  200                            
Molecular formula                    
UV λmax nm                            
IR υmax                                    
Mass Spectrum m/z                   
1
H-NMR                                   
13
C-NMR 
   
 
 
 
 
 
 
 
:White Powder 
: C29H44O2 
: 221 
: 3437, 2929, 1707, 1621 
: 424                                 
: Refer Table 3.3 
: Refer Table 3.3 
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O
18
3
4
5 7
810
9
11
12
14
13
15
16
17
19
20
21 22 24
29
6
2
1
23
28
30
OHO
27
26
25
                                 
 
Schizandronic Acid  201              
Molecular formula                    
UV λmax nm                            
IR υmax                                    
Mass Spectrum m/z                   
1
H-NMR                                   
13
C-NMR                                   
: Colorless Needle Crystal 
: C30H46O3 
: 212 
: 3393, 2934, 2869, 1705 
: 454 
: Refer Table 3.4 
: Refer Table 3.4 
 
HO
O
O
1
2
3
4 5
6
7
9
810
11
12
13
14
15
16
17
19
22
23 24
21
20
30
18
29 28  
Cabraleahydroxylactone  202 
Molecular formula                    
UV λmax nm                            
IR υmax                                    
Mass Spectrum m/z                   
1
H-NMR                                   
13
C-NMR          
 
 
 
 
 
 
 
 
 
 
: Colorless Crystal 
: C27H44O3 
: - 
: 3550, 2900, 2810, 1760 
: 416 
: Refer Table 3.5 
: Refer Table 3.5 
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O
18
3
4
5 7
810
9
11
12
14
13
15
16
17
20
21 22
25
27
2
1
23
19
6
24 26
OH
30
2829  
                         
24(E)-cycloart-24-ene-26-ol-3-one  203                     
Molecular formula                    
UV λmax nm                            
IR υmax                                    
Mass Spectrum m/z                   
1
H-NMR                                   
13
C-NMR       
 
 
 
HO
18
3
4
5 7
810
9
11
12
14
13
15
16
17
19
20
21 22 24
30
6
2
1
23
29 28
26
27
25 O
                            
: Colorless Amorphous Solid 
: C30H48O2 
: 237 
: 3445, 2942, 2870, 1705 
: 440 
: Refer Table 3.6 
: Refer Table 3.6 
 
 
 
 
 
 
 
24(E)-3β-hydroxycycloart-24-ene-26-al 204 
Molecular formula                    
UV λmax nm                            
IR υmax                                    
Mass Spectrum m/z                   
1
H-NMR                                   
13
C-NMR                                   
: Pale Yellow Gel  
: C30H48O2 
: 220 
: 3429, 2937, 2868, 1689 
: 440 
: Refer Table 3.7 
: Refer Table 3.7 
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HO
18
3
4
5 7
810
9
11
12
14
13
15
16
17
20
21 22
25
27
2
1
23
19
6
24
28
26
29
 
β-sitosterol  205 
Molecular formula                    
UV λmax nm                            
IR υmax                                    
Mass Spectrum m/z                   
1
H-NMR                                   
13
C-NMR                             
 
       
 
 
: Colorless Crystal 
: C29H50O 
: 211 
: 3418, 2936, 1644, 1463 
: 414 
: Refer Table 3.8 
: Refer Table 3.8 
 
HO
18
3
4
5 7
810
9
11
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13
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16
17
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27
2
1
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O
6
24
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Stigmast-5-ene-28-one  206 
Molecular formula                    
UV λmax nm                            
IR υmax                                    
Mass Spectrum m/z                   
1
H-NMR                                   
 13
C-NMR                                   
 
 
 
 
 
: Colorless Crystal 
: C29H48O2 
: 208 
: 3419, 2934, 2852, 1713 
: 412 
: Refer Table 3.9 
: Refer Table 3.9 
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